Unique ID issued by UMIN | UMIN000002474 |
---|---|
Receipt number | R000003035 |
Scientific Title | Preventive effect of vit K, vit D and, risedronate on 3-dimensional trabecular microstructure in patients with IgA nephropathy on glucocorticoid treatment |
Date of disclosure of the study information | 2009/10/01 |
Last modified on | 2013/11/20 22:20:53 |
Preventive effect of vit K, vit D and, risedronate on 3-dimensional trabecular microstructure in patients with IgA nephropathy on glucocorticoid treatment
The Preventive Risedronate Intervention for those Undergoing Steroid therapy with IgA nephropathy (PRIUS-IgA Study )
Preventive effect of vit K, vit D and, risedronate on 3-dimensional trabecular microstructure in patients with IgA nephropathy on glucocorticoid treatment
The Preventive Risedronate Intervention for those Undergoing Steroid therapy with IgA nephropathy (PRIUS-IgA Study )
Japan |
Glucocorticoid induced osteoporosis in patients with IgA nephropathy
Medicine in general | Nephrology | Orthopedics |
Others
NO
To compare the preventive effect of VitK, VitD and Risedronate on 3-dimensional trabecular bone structure in patients with IgA nephropathy who start receiving glucocorticoid therapy.
Efficacy
Confirmatory
Pragmatic
Not applicable
Changes in 3-dimensional trabecular bone structure at 6-month after the start of intervention
Changes in bone turnover markers and bone mineral density
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
3
Prevention
Medicine |
Menatetrenone 45mg/day for 6 months
Calcitriol 0.5 microgram/day for 6 months
Risedronate 17.5mg/week for 6 months
18 | years-old | <= |
Not applicable |
Male and Female
Inpatients with IgA nephropathy who start glucocorticoid therapy for the first time in the Department of nephrology of Osaka university hospital
1, women who hope for future pregnancy
2, patients who already have had osteopenia or osteoporosis
3, patients with chronic kidney disease stage 3-5
4, postmenopausal women
5, patients with any prior history of glucocorticoid therapy
30
1st name | |
Middle name | |
Last name | Yoshitaka Isaka |
Osaka University Hospital
Nephrology
2-15 Yamada-oka Suita, Osaka, 565-0871, Japan
06-6879-3857
1st name | |
Middle name | |
Last name | Yoshitaka Isaka |
Osaka University Hospital
Nephrology
2-15 Yamada-oka Suita, Osaka, 565-0871, Japan
06-6879-3857
isaka@kid.med.osaka-u.ac.jp
Osaka University Hospital
Department of nephrology
Eisai
Profit organization
Japan
NO
大阪大学医学部附属病院(大阪府)
内田クリニック(大阪府)
2009 | Year | 10 | Month | 01 | Day |
Published
http://www.ncbi.nlm.nih.gov/pubmed/23832575
Completed
2007 | Year | 01 | Month | 04 | Day |
2007 | Year | 01 | Month | 01 | Day |
2015 | Year | 12 | Month | 01 | Day |
2009 | Year | 09 | Month | 09 | Day |
2013 | Year | 11 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003035
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |